BackXOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A Overview
XOMA Royalty Corp. - 8.625% PRF PERPETUAL USD 25 - Ser A

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A Return on Equity

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A (XOMAP) has a ROE of 27.91%, above the Healthcare sector average of 20.86%.

Get informed when a big investor buys or sells

+ Follow

ROE

27.91%

Return on Equity

27.91%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A (XOMAP) FAQ

As of the most recent data, XOMAP shows a ROE of 27.91%. That is above the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 20.86%. XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A is at 27.91%, which is higher that average. That is roughly 33.8% above the sector mean. Use the comparison chart on this page to see how XOMAP stacks up against individual peers as well.

Check the historical chart to see whether XOMAP's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 27.91%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 20.86%, while XOMAP is at 27.91%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.